UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...

Deutsche Bank upgraded UBS (UBS) to Buy from Hold with a price target of CHF 37, up from CHF 29.Maximize Your Portfolio with Data Driven ...

Deutsche Bank (ETR:DBKGn) analyst Benjamin Goy upgraded UBS AG (UBSG:SW) (NYSE: UBS) stock rating from Hold to Buy and increased the price target from CHF29.00 to CHF37.00. Goy noted that UBS's share ...

Crazy' busy FIG market ◆ UBS goes big in large year for senior holdco redemptions ◆ Deutsche prints senior debt seemingly ...

UBS analyst Graham Doyle maintained a Hold rating on Siemens Healthineers AG (SEMHF – Research Report) today and set a price target of €53.00.

Swiss banking giant UBS said Tuesday that it remained on track to substantially wrap up its mega-merger with Credit Suisse by ...

Swiss banking giant UBS on Tuesday posted $770 million in fourth-quarter net profit, compared with a mean forecast of $886.4 ...

Investment banks are benefiting from volatile markets, but their future profitability hinges on the regulatory backdrop.

The Swiss banking giant, which has been experimenting with blockchain, tapped the layer-2 firm to test whether it could scale ...

Deutsche Bank Aktiengesellschaft upgraded shares of Honeywell International (NASDAQ:HON – Free Report) from a hold rating to ...

NET PROFIT FORECAST: UBS's quarterly net profit is forecast to be at $483 million, according to the consensus. The bank reported a net loss of $279 million for the year-earlier period, hit by around ...

UBS analysts increased the price target on Axsome Therapeutics (NASDAQ:AXSM) shares to $133.00, up from the previous $105.00, while maintaining a Buy rating on the stock. The company, currently valued ...